Marlio Charles Mosseri
Major shareholder at Nuvectis Pharma · 7 reported transactions in 1 company · latest trade Jun 30, 2026
Their record
Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.
Typical move −18.0%, S&P 500 +14.4% over the same days.
Their trades
Bought | Jun 30, 2026 | Jun 30, 2026 close $18.39 → Oct 28, 2026 close $18.36. S&P 500 +3.4% over the same days. | ||
Bought | Oct 27, 2025 | Oct 27, 2025 close $6.55 → Oct 28, 2026 close $18.36. S&P 500 +12.7% over the same days. | ||
Bought | Oct 24, 2025 | Oct 24, 2025 close $6.20 → Oct 28, 2026 close $18.36. S&P 500 +14.0% over the same days. | ||
Bought | Oct 23, 2025 | Oct 23, 2025 close $6.01 → Oct 28, 2026 close $18.36. S&P 500 +15.0% over the same days. | ||
Bought | Jun 20, 2025 | Jun 20, 2025 close $8.13 → Oct 28, 2026 close $18.36. S&P 500 +30.0% over the same days. | ||
Bought | Jun 18, 2025 | Jun 18, 2025 close $8.05 → Oct 28, 2026 close $18.36. S&P 500 +29.3% over the same days. | ||
Bought | Jun 17, 2025 | Jun 17, 2025 close $8.11 → Oct 28, 2026 close $18.36. S&P 500 +29.3% over the same days. |
BoughtNuvectis Pharma
$916K
Jun 30, 2026 close $18.39 → Oct 28, 2026 close $18.36. S&P 500 +3.4% over the same days.
BoughtNuvectis Pharma
$457.4K
Oct 27, 2025 close $6.55 → Oct 28, 2026 close $18.36. S&P 500 +12.7% over the same days.
BoughtNuvectis Pharma
$215.5K
Oct 24, 2025 close $6.20 → Oct 28, 2026 close $18.36. S&P 500 +14.0% over the same days.
BoughtNuvectis Pharma
$284.2K
Oct 23, 2025 close $6.01 → Oct 28, 2026 close $18.36. S&P 500 +15.0% over the same days.
BoughtNuvectis Pharma
$44.8K
Jun 20, 2025 close $8.13 → Oct 28, 2026 close $18.36. S&P 500 +30.0% over the same days.
BoughtNuvectis Pharma
$225.7K
Jun 18, 2025 close $8.05 → Oct 28, 2026 close $18.36. S&P 500 +29.3% over the same days.
BoughtNuvectis Pharma
$43.8K
Jun 17, 2025 close $8.11 → Oct 28, 2026 close $18.36. S&P 500 +29.3% over the same days.